The Group's principal activities are to discover, develop and sell drugs. The Group specializes in developing drugs for bone and joint diseases such as osteoarthritis, osteoporosis and rheumatoid arthritis. The Group also offers services to pharmaceutical and biotech companies such as encompassing target discovery to validation and drug discovery services through to delivery of pre-clinical candidates. The Group also works in partnership with some major pharmaceutical and biotechnology companies such as Amgen, GlaxoSmithKline, Novartis and Wyeth. The Group operates mainly in Belgium, Netherlands, France, the United Kingdom and the United States.
Alacra Alerts:
Receive alerts on the latest reports on Galapagos Genomics NV
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
